These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2000893)

  • 1. Diabetic nephropathy: changing concepts of pathogenesis and treatment.
    Bell DS
    Am J Med Sci; 1991 Mar; 301(3):195-200. PubMed ID: 2000893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy: early detection, prevention and management.
    Maher JF
    Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dealing with diabetic nephropathy.
    Bell DS; Alele J
    Postgrad Med; 1999 Feb; 105(2):83-7, 91-4. PubMed ID: 10026705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy--prevention and treatment.
    Agarwal DK
    J Indian Med Assoc; 2002 Mar; 100(3):158-60, 162-3. PubMed ID: 12408275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?
    Gallagher H; Suckling RJ
    Diabetes Obes Metab; 2016 Jul; 18(7):641-7. PubMed ID: 26743887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission and regression of diabetic nephropathy.
    Makino H; Nakamura Y; Wada J
    Hypertens Res; 2003 Jul; 26(7):515-9. PubMed ID: 12924617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy.
    Ibrahim HA; Vora JP
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):239-64. PubMed ID: 10761865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephropathy in type 2 diabetes.
    Ritz E
    J Intern Med; 1999 Feb; 245(2):111-26. PubMed ID: 10081514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserving the diabetic kidney.
    Poirier SJ
    J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic progress. III: Diabetic nephropathy.
    Maxwell SR; Gittoes NJ
    J Clin Pharm Ther; 1994 Oct; 19(5):285-93. PubMed ID: 7806599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of diabetic nephropathy in current nephrological practice.
    Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
    Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.